Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1804
interventional 1289
Observational 472
Registry 43

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 464
Drug|placebo 317
Other 119
Device 62
Procedure 57
Behavioral 43
Dietary Supplement 33
Biological 29
Dietary Supplement|placebo 19
Diagnostic Test 18
Drug|Other 17
Biological|placebo 14
Device|Other 14
Drug|Procedure 10
Other|Procedure 10
Device|Drug 7
Biological|Drug 5
Genetic 5
Behavioral|Other 4
Dietary Supplement|Other 4
Device|placebo 3
Device|Procedure 3
Dietary Supplement|Drug 3
Combination Product 2
Drug|placebo|Procedure 2
placebo|Procedure 2
Radiation 2
Behavioral|Device 1
Behavioral|Dietary Supplement 1
Behavioral|Drug 1
Behavioral|Drug|placebo 1
Biological|Device 1
Biological|Diagnostic Test|Other 1
Biological|Drug|placebo 1
Biological|Other 1
Combination Product|Drug 1
Combination Product|placebo 1
Device|Drug|Procedure 1
Diagnostic Test|Drug 1
Diagnostic Test|Drug|Other 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Other|Procedure 1
Dietary Supplement|Procedure 1
Drug|Other|placebo 1
Drug|Other|placebo|Procedure 1
Drug|placebo|Radiation 1
Drug|Procedure|Radiation 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 368
NA 96
France 85
United Kingdom 68
China 54
Spain 41
Canada 40
India 38
Germany 31
United States|Canada 25
Italy 24
Belgium 18
Korea, Republic of 18
Japan 15
Australia 13
Israel 11
Brazil 10
Denmark 9
Mexico 9
Austria 8
Switzerland 7
Turkey 7
Iran, Islamic Republic of 5
Sweden 5
Taiwan 5
United States|Canada|United Kingdom 5
Egypt 4
Indonesia 4
Netherlands 4
Poland 4
United States|Puerto Rico 4
Australia|New Zealand 3
Greece 3
Hong Kong 3
Russian Federation 3
United States|Australia|Canada|Denmark|Germany|Ireland|Israel|Poland|Spain|Switzerland|United Kingdom 3
United States|Australia|Canada|New Zealand 3
United States|Germany 3
Australia|United Kingdom 2
Belgium|France 2
Belgium|Hungary|North Macedonia|Poland|Serbia|Slovakia|Ukraine 2
Belgium|Netherlands 2
Bulgaria 2
France|Belgium 2
France|Germany|Italy|Netherlands|Spain|United Kingdom 2
Germany|Hungary|Italy|Poland|Spain|United Kingdom 2
Hungary 2
Ireland 2
Norway 2
Romania 2
Thailand 2
United States|Australia 2
United States|Australia|Austria|Belgium|Canada|Czechia|France|Germany|Greece|Italy|Netherlands|Sweden|United Kingdom 2
United States|Australia|Belgium|Canada|Denmark|France|Germany|Sweden|United Kingdom 2
United States|Australia|Canada 2
United States|Australia|Canada|Czech Republic|France|Germany|Ireland|United Kingdom 2
United States|Australia|Canada|Ireland|United Kingdom 2
United States|Belgium|Canada|France|Germany|Israel|Italy|Netherlands|Spain|Sweden|United Kingdom 2
United States|Belgium|Canada|Germany|Netherlands 2
United States|Belgium|France 2
United States|Canada|Germany|United Kingdom 2
United States|Germany|Spain 2
United States|Israel 2
United States|Japan 2
Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Czech Republic|France|Germany|Greece|Hungary|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Portugal|Russian Federation|South Africa|Spain|Taiwan|Turkey|United Kingdom 1
Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Czechia|France|Germany|Greece|Hungary|Ireland|Italy|Mexico|Netherlands|Portugal|Russian Federation|Spain|United Kingdom 1
Argentina|Canada 1
Australia|Belgium|Czechia|Germany|Ireland|United Kingdom 1
Australia|Belgium|Denmark|France|Germany|Ireland|Poland|Switzerland|United Kingdom 1
Australia|Belgium|Germany|Greece|Israel|Italy|Netherlands|New Zealand|Portugal|Spain|Switzerland|United Kingdom 1
Australia|Belgium|Germany|United Kingdom 1
Australia|Czech Republic|Germany|Ireland|United Kingdom 1
Australia|Czechia|Germany|United Kingdom 1
Australia|Ireland|United Kingdom 1
Austria|Australia|Canada|France|Germany|Italy|Korea, Republic of|Spain|Switzerland|Thailand 1
Austria|Belgium|Germany|Hungary|Ireland|Italy|Poland|Spain|Sweden 1
Austria|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Italy|Poland|Spain|Taiwan|United Kingdom 1
Austria|France|Germany|Italy 1
Belgium|Bulgaria|France|Germany|Italy|Poland|United Kingdom 1
Belgium|Bulgaria|Germany|Greece|Netherlands|Serbia|Sweden|United Kingdom 1
Belgium|Canada|Czechia|Egypt|Germany|Greece|Hungary|Israel|Italy|Netherlands|South Africa|Spain|Turkey 1
Belgium|Denmark|Finland|Germany|Italy|Netherlands|Spain|United Kingdom 1
Belgium|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
Belgium|France|Germany|Italy|Spain|United Kingdom 1
Bulgaria|Canada|Denmark|France|Germany|Greece|Hungary|Ireland|Italy|Netherlands|Poland|Serbia|Belgium|Austria|Slovakia|Spain|United Kingdom 1
Bulgaria|Croatia|Finland|France|Oman|Romania|Slovakia|Sweden|Ukraine 1
Bulgaria|Egypt|Estonia|India|Latvia|Lithuania|Romania|Russian Federation|South Africa 1
Bulgaria|Hungary|Poland|United Kingdom 1
Canada|Egypt|France|Germany|Greece|Hungary|Italy|Romania|Russian Federation|Switzerland 1
Canada|France|Ireland|Italy|Netherlands|Russian Federation 1
Canada|France|Italy|Portugal|United Kingdom 1
Canada|France|United States|Australia|Austria|Israel|Spain 1
China|Korea, Republic of 1
Cuba 1
Czech Republic|Hungary|Poland|Spain 1
Czech Republic|Moldova, Republic of|Slovakia 1
Czechia|France|Germany|Hungary|Poland|Russian Federation|Spain|Ukraine 1
Czechia|United States|Argentina|Australia|Belgium|Canada|Chile|Colombia|Denmark|Finland|France|Germany|Italy|Mexico|Netherlands|Portugal|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Denmark|Germany|Norway|Sweden|United Kingdom 1
Denmark|Germany|Poland|Russian Federation|Sweden|United Kingdom 1
Denmark|Norway|Sweden 1
Estonia|Russian Federation 1
Finland 1
France|Italy|Portugal|Spain|Switzerland|United Kingdom 1
France|Italy|Romania|United Kingdom 1
France|Italy|Spain|Tunisia 1
France|Poland|Ukraine 1
France|United Kingdom 1
France|United States|Austria|Belgium|Denmark|Germany|Ireland|Italy|Netherlands|Portugal|Spain|Switzerland|United Kingdom 1
France|United States|Austria|Canada|Germany|Netherlands|Spain|United Kingdom 1
France|United States|Belgium|Canada|Czechia|Hungary|Netherlands|Serbia|Slovakia|Spain|United Kingdom 1
Germany|Ireland|Spain|Switzerland|United Kingdom 1
Germany|Israel 1
Germany|Netherlands 1
Germany|Poland 1
Germany|Switzerland 1
Germany|United Kingdom 1
Germany|United States|Australia|Belgium|Canada|Denmark|France|New Zealand|United Kingdom 1
Guadeloupe 1
Holy See (Vatican City State)|Italy 1
Hong Kong|Korea, Republic of|Singapore|Taiwan|Vietnam 1
Hungary|Spain 1
Ireland|Italy|Germany|United States|Australia|Austria|Belgium|Canada|France|United Kingdom 1
Ireland|United Kingdom 1
Ireland|United States|Australia|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
Ireland|United States|Australia|United Kingdom 1
Italy|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|France|Germany|Greece|Israel|Netherlands|Poland|Spain|United Kingdom 1
Italy|United States|Australia|Austria|Belgium|Canada|Denmark|France|Germany|Ireland|Israel|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
Italy|United States|Australia|Canada|Germany|Hungary|Ireland|Israel|Korea, Republic of|Latvia|Poland|Romania|South Africa|Spain|Taiwan|United Kingdom 1
Kazakhstan 1
Malaysia 1
Netherlands|Poland 1
Netherlands|United Kingdom 1
Pakistan 1
Peru|Spain 1
Portugal 1
Singapore 1
Slovakia 1
Sweden|Austria|Belgium|Denmark|France|Germany|Italy|United Kingdom 1
Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Denmark|Estonia|Finland|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Serbia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Croatia|Denmark|France|Hungary|Israel|Italy|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Estonia|Germany|Hungary|Italy|Lithuania|Spain 1
United States|Argentina|Australia|Belgium|Canada|Czechia|Hungary|Israel|Italy|Mexico|New Zealand|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Ukraine 1
United States|Argentina|Australia|Canada|Chile|Colombia|Czechia|Denmark|France|Germany|Greece|Israel|Italy|Korea, Republic of|Mexico|Portugal|Spain|Turkey|United Kingdom 1
United States|Argentina|Australia|Canada|France|Germany|Greece|Israel|Italy|New Zealand|Poland|Portugal 1
United States|Argentina|Australia|Canada|France|Germany|Hungary|Italy|Mexico|Spain 1
United States|Argentina|Belgium|Canada|France|Germany|Netherlands 1
United States|Argentina|Canada|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Poland|South Africa 1
United States|Australia|Austria|Belgium|Canada|Croatia|Czech Republic|France|Germany|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Serbia|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Ireland|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czech Republic|France|Germany|Hungary|Ireland|Israel|Italy|Poland|Portugal|Russian Federation|Slovakia|South Africa|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Denmark|France|Germany|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Denmark|Germany|Italy|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Netherlands|Poland|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Canada 1
United States|Australia|Belgium|Bulgaria|Denmark|Germany|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Singapore|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Chile|China|Czechia|Finland|France|Germany|Greece|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Portugal|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Czech Republic|France|Germany|Ireland|Israel|Italy|Japan|Korea, Republic of|Spain|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Ireland|Israel|Italy|Netherlands|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Ireland|Poland|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Italy|Netherlands|Spain 1
United States|Australia|Belgium|Canada|France|Germany|India|Italy|Japan|Korea, Republic of|Mexico|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Israel|Italy|Netherlands|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Italy|Japan|Mexico|Peru|Poland|Spain|United Kingdom 1
United States|Australia|Belgium|Chile|Czechia|Denmark|Germany|Greece|Peru|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Belgium|China|Czech Republic|France|Germany|India|Ireland|Israel|Italy|Japan|United Kingdom 1
United States|Australia|Belgium|Czechia|Finland|France|Germany|Hungary|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy|Netherlands|New Zealand|Portugal|Russian Federation|United Kingdom 1
United States|Australia|Belgium|France|Germany|New Zealand|United Kingdom 1
United States|Australia|Belgium|France|Germany|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Belgium|Germany|Ireland|Netherlands|United Kingdom 1
United States|Australia|Belgium|Netherlands 1
United States|Australia|Brazil|Canada|Colombia|Germany|Greece|Romania|Russian Federation|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Bulgaria|Canada|India|New Zealand|South Africa 1
United States|Australia|Canada|Chile|Colombia|France|Germany|Hungary|Israel|Italy|Mexico|Netherlands|Spain|United Kingdom 1
United States|Australia|Canada|China|France|Germany|India|Israel|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Australia|Canada|Czech Republic|France|Germany|Ireland|Italy|Netherlands|Sweden|United Kingdom 1
United States|Australia|Canada|Denmark|Germany|Israel|Norway|Sweden|United Kingdom 1
United States|Australia|Canada|Former Serbia and Montenegro|France|Georgia|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Peru|Poland|Romania|Spain|United Kingdom 1
United States|Australia|Canada|France|Germany|Hungary|New Zealand|Poland|Puerto Rico|Spain|Ukraine|United Kingdom 1
United States|Australia|Canada|France|Germany|Ireland|United Kingdom 1
United States|Australia|Canada|France|Germany|Israel|Italy|Slovenia|South Africa|Spain|Sweden|Turkey 1
United States|Australia|Canada|France|Germany|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Germany|Ireland|United Kingdom 1
United States|Australia|Canada|Israel|New Zealand 1
United States|Australia|Chile|Colombia|Mexico|Peru 1
United States|Australia|France|New Zealand|Spain 1
United States|Australia|Germany|Ireland|Spain|United Kingdom 1
United States|Australia|Israel|New Zealand 1
United States|Australia|New Zealand 1
United States|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Greece|Hungary|Italy|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Spain|Sweden|United Kingdom 1
United States|Austria|Belgium|Denmark|France|Germany|Greece|Israel|Italy|Netherlands|Spain|United Kingdom 1
United States|Austria|Belgium|France|Germany|Italy|Netherlands|Poland|Spain 1
United States|Austria|Canada|France|Germany|Spain|United Kingdom 1
United States|Belgium 1
United States|Belgium|Canada|Czechia|Denmark|France|Germany|Italy|Spain|United Kingdom 1
United States|Belgium|Canada|France|Germany|Israel|Italy|Poland|Spain|United Kingdom 1
United States|Belgium|Canada|France|Germany|Italy|United Kingdom 1
United States|Belgium|Denmark 1
United States|Belgium|Denmark|France|Germany|Italy|Spain|United Kingdom 1
United States|Belgium|France|Germany|Italy|Poland|United Kingdom 1
United States|Belgium|France|United Kingdom 1
United States|Belgium|Netherlands|Serbia|Spain|United Kingdom 1
United States|Belgium|Netherlands|United Kingdom 1
United States|Bulgaria 1
United States|Bulgaria|Canada|Czechia|France|Greece|Hungary|Ireland|Israel|Italy|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Spain|Taiwan|United Kingdom|Vietnam 1
United States|Canada|Chile|China|Finland|France|Germany|Greece|India|Japan|Korea, Republic of|Mexico|Netherlands|Portugal|Russian Federation|Spain|Turkey 1
United States|Canada|Chile|Mexico|Spain 1
United States|Canada|Czechia|Hungary|Israel|Poland|Spain 1
United States|Canada|Denmark|France|Germany 1
United States|Canada|Denmark|France|Germany|Ireland|Italy|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain 1
United States|Canada|Denmark|Germany|Sweden 1
United States|Canada|France|Germany|Ireland|Italy|United Kingdom 1
United States|Canada|France|Germany|Israel 1
United States|Canada|France|Germany|Israel|Italy|Switzerland|United Kingdom 1
United States|Canada|France|Germany|Italy|Netherlands 1
United States|Canada|France|Italy|Switzerland|United Kingdom 1
United States|Canada|Germany 1
United States|Canada|Turkey 1
United States|Czechia|Germany|Italy|Netherlands|Spain|Switzerland 1
United States|Czechia|Hungary|Israel|Poland|Spain 1
United States|France|Germany 1
United States|France|Germany|Ireland|Israel|United Kingdom 1
United States|France|Germany|Israel|Italy|Netherlands|Sweden|Switzerland|United Kingdom 1
United States|France|Germany|Italy|Poland|Spain 1
United States|France|Ireland|United Kingdom 1
United States|France|Spain|Switzerland 1
United States|Germany|Italy|Switzerland|United Kingdom 1
United States|Germany|Japan|United Kingdom 1
United States|Germany|Netherlands 1
United States|Germany|Netherlands|Portugal|United Kingdom 1
United States|Hong Kong|Taiwan 1
United States|Hungary|Israel|South Africa|Spain 1
United States|Ireland|Israel|United Kingdom 1
United States|Italy 1
United States|Italy|United Kingdom 1
United States|Netherlands 1
United States|Poland 1
United States|Russian Federation 1
United States|Spain 1
United States|Spain|United Kingdom 1
United States|United Kingdom 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 772
2 66
3 33
4 30
5 21
6 18
7 16
8 18
9 12
10 11
11 16
12 9
13 7
14 7
15 10
16 6
17 12
18 6
19 7
20 10
21 8
22 2
23 9
24 4
25 7
26 4
27 5
28 5
29 8
30 3
31 4
32 3
33 5
34 2
35 3
36 6
37 3
38 7
39 2
40 5
41 2
42 2
43 2
44 3
45 2
46 4
47 1
48 2
49 2
50 4
53 5
54 3
55 1
56 4
58 4
59 1
61 2
65 3
67 1
68 1
69 1
70 1
71 2
72 2
75 2
76 1
79 1
82 1
84 1
85 1
86 2
88 1
90 1
91 2
92 2
93 1
94 2
95 2
97 1
98 1
99 1
100 2
101 2
103 1
106 1
107 1
108 2
109 2
110 1
112 2
113 2
115 2
117 1
121 2
130 1
132 1
159 1
167 1
173 1
180 1
227 1
326 1

Phase

Phase Study_Count
N/A 426
Phase 2 278
Phase 3 228
Phase 1 127
Phase 4 123
Phase 1/Phase 2 68
Phase 2/Phase 3 28
Early Phase 1 11

Number of Arms

Number_of_Arms Count_of_Studies
1 320
2 619
3 126
4 62
5 13
6 12
7 6
8 4
9 3
10 2
11 1
12 4
13 1
15 2
16 1
NA 113

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.0 1.0000 2.00000 6.00000 6.00000 10.0000 2.0000 1.0000
1st Qu. 17.0 26.5000 10.50000 17.75000 20.00000 48.5000 57.0000 25.0000
Median 25.0 50.0000 18.00000 30.00000 49.00000 76.0000 128.0000 60.0000
Mean 38.0 121.9882 29.14961 45.32353 81.04332 147.1923 217.1956 140.7603
3rd Qu. 43.5 100.0000 30.00000 59.25000 100.00000 151.5000 274.0000 157.0000
Max. 150.0 4000.0000 240.00000 266.00000 510.00000 1010.0000 2000.0000 1048.0000

Trial Group Type

group_type Group_Count
Experimental 1416
Active Comparator 463
Placebo Comparator 434
Other 141
NA 113
No Intervention 89
Sham Comparator 17

Intervention Model

intervention_model Study_Count
Parallel Assignment 682
Single Group Assignment 407
Crossover Assignment 145
NA 28
Sequential Assignment 22
Factorial Assignment 5

Primary Purpose

primary_purpose Study_Count
Treatment 904
Diagnostic 92
Prevention 76
Basic Science 54
Supportive Care 52
Other 48
NA 28
Health Services Research 16
Screening 16
Educational/Counseling/Training 2
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 160
France 59
United Kingdom 31
NA 25
China 20
Germany 18
Canada 14
Italy 12
Denmark 11
India 10
Belgium 8
Switzerland 8
Israel 7
Mexico 7
Netherlands 7
Spain 7
Turkey 7
Austria 4
Brazil 4
Greece 4
Korea, Republic of 4
Japan 3
Sweden 3
Taiwan 3
United States|Canada 3
Austria|Germany 2
Czechia 2
Russian Federation 2
Argentina 1
Australia 1
Austria|Denmark|Finland|France|Germany|Ireland|Italy|Norway|Sweden|United Kingdom 1
Belgium|China|Denmark|France|Germany|Greece|Hong Kong|Italy|Romania 1
China|Indonesia|Japan|Thailand|Turkey 1
China|Thailand|Turkey 1
Denmark|Lithuania 1
Egypt 1
Finland 1
France|Italy|Netherlands 1
Germany|Italy 1
Germany|Netherlands 1
Hong Kong 1
India|Sri Lanka 1
Ireland 1
Italy|Netherlands|United Kingdom 1
Malta 1
Netherlands|United Kingdom 1
Norway 1
Poland 1
Qatar 1
Romania 1
Singapore 1
Spain|Austria|Belgium|Denmark|France|Germany|Hungary|Italy|Netherlands|Portugal|Slovakia|Switzerland|Turkey|United Kingdom 1
United States|Australia 1
United States|Iceland 1
Zambia 1

Sites per Study

Site_count Study_Count
1 378
2 25
3 13
4 8
5 3
7 8
8 4
9 5
10 2
11 1
12 2
13 2
14 1
15 2
16 1
17 3
18 1
26 3
31 2
36 1
38 2
45 1
47 1
52 1
106 1
123 1

Enrollment Metrics

Measure Observational
Min 0.0
1st Qu 50.0
Median 100.0
Mean 215776.9
3rd Qu 249.0
Max 99999999.0

Observation Model

observational_model Study_Count
Cohort 278
Case-Only 59
Case-Control 53
NA 27
Case Control 21
Other 18
Family-Based 9
Case-Crossover 4
Defined Population 1
Defined Population, Natural History 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 333
Cross-Sectional 63
Retrospective 38
Other 18
NA 15
Cross-Sectional, Prospective 3
Longitudinal 1
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
China 7
United States 7
Korea, Republic of 6
Belgium 2
Denmark 2
France 2
Taiwan 2
United Kingdom 2
Austria 1
Belgium|Luxembourg 1
Germany|Switzerland 1
Israel 1
Italy 1
Japan 1
NA 1
Netherlands 1
Spain 1
Switzerland 1
Turkey 1
United States|Australia|Canada|France|Germany|Italy|New Zealand|Puerto Rico|Spain|United Kingdom 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 27
2 2
3 1
5 3
6 1
8 1
9 1
15 1
23 1
30 1
42 1
47 2
138 1

Enrollment Metrics

Measure Registries
Min 8.0000
1st Qu 200.0000
Median 500.0000
Mean 902.9767
3rd Qu 1000.0000
Max 10000.0000

Registry Model

observational_model Study_Count
Cohort 33
Other 4
Case-Control 3
Case-Only 3

Time Perspective

time_perspective Study_Count
Prospective 37
Cross-Sectional 4
Other 2

Follow-up

target_duration Study_Count
5 Years 10
3 Years 8
10 Years 5
2 Years 5
20 Years 4
1 Year 2
6 Months 2
1 Day 1
12 Months 1
15 Years 1
192 Weeks 1
3 Months 1
6 Weeks 1
6 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02194881 Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation https://ClinicalTrials.gov/show/NCT02194881 Completed Assistance Publique - Hôpitaux de Paris 2016-02-29
NCT03757741 Inflammation, Fibrosis and Risk of Recurrence After Atrial Fibrillation Ablation https://ClinicalTrials.gov/show/NCT03757741 Recruiting Cardio Med Medical Center 2021-02-01
NCT03405987 Association of T1-mapping and LV Strain Analysis by CMR https://ClinicalTrials.gov/show/NCT03405987 Recruiting Medical University of Vienna 2020-12-01
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study https://ClinicalTrials.gov/show/NCT03405909 Recruiting University Hospital Erlangen 2020-02-29
NCT03391128 Circulating P3NP and Cardiovascular Events in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT03391128 Completed Toujinkai Hospital 2005-01-31
NCT03381157 Fidgety Movements in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03381157 Completed Hacettepe University 2019-02-02
NCT03377686 Breath Analysis in Children by New Point-of-care Instruments https://ClinicalTrials.gov/show/NCT03377686 Completed Maastricht University Medical Center 2017-11-30
NCT03593434 Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI https://ClinicalTrials.gov/show/NCT03593434 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-07-30
NCT02022150 Body Composition Analysis in Cirrhotic Undergoing Paracentesis https://ClinicalTrials.gov/show/NCT02022150 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2021-06-30
NCT03345498 Entecavir for Decompensated HBV Cirrhosis https://ClinicalTrials.gov/show/NCT03345498 Completed Sanjay Gandhi Postgraduate Institute of Medical Sciences 2018-06-30
NCT03820349 Cystic Fibrosis and Cognitive Function https://ClinicalTrials.gov/show/NCT03820349 Recruiting University of Minnesota 2021-04-30
NCT03335202 Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03335202 Recruiting University of Kiel 2019-09-30
NCT03323983 Exploratory Study on Link Between Dynamic Hyperinflation and Lung Clearance Index in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03323983 Completed Centre Hospitalier Universitaire de Besancon 2016-11-30
NCT03318328 Evaluation of Food Insecurity in Adults and Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03318328 Completed St. Luke’s Health System, Boise, Idaho 2015-03-31
NCT03281200 Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain https://ClinicalTrials.gov/show/NCT03281200 Completed Boehringer Ingelheim 2018-06-07
NCT03277651 Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT03277651 Recruiting Shanghai Zhongshan Hospital 2019-12-31
NCT03242798 Assessment of Nutritional Status of Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03242798 Active, not recruiting Harokopio University 2018-10-31
NCT03229213 Interactive Video Game Responses in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03229213 Completed Pontificia Universidade Católica do Rio Grande do Sul 2019-03-31
NCT03214796 Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status https://ClinicalTrials.gov/show/NCT03214796 Recruiting Medical University of Graz 2020-12-31
NCT03211507 Idiopathic Pulmonary Fibrosis Job Exposures Study https://ClinicalTrials.gov/show/NCT03211507 Completed Imperial College London 2019-10-05
NCT03198104 Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI https://ClinicalTrials.gov/show/NCT03198104 Completed Perspectum Diagnostics Ltd 2019-03-01
NCT03176290 Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT03176290 Completed Ain Shams University 2016-12-31
NCT03156426 Prognostic Biomarkers For Acute Kidney Injury In Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03156426 Completed University of Edinburgh 2017-11-15
NCT03144700 The Natural History and Prognostic Factors of Compensated Cirrhosis. https://ClinicalTrials.gov/show/NCT03144700 Recruiting Institute of Liver and Biliary Sciences, India 2021-01-31
NCT03137719 Infections in Hospitalized Cirrhotic Patients https://ClinicalTrials.gov/show/NCT03137719 Active, not recruiting Baylor Research Institute 2020-05-30
NCT03133949 Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria https://ClinicalTrials.gov/show/NCT03133949 Recruiting Centre Hospitalier Universitaire, Amiens 2020-07-08
NCT03121404 Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting https://ClinicalTrials.gov/show/NCT03121404 Recruiting The Cleveland Clinic 2025-12-31
NCT03115619 Quality of Life Study in Participants With IPF Under Pirfenidone Treatment https://ClinicalTrials.gov/show/NCT03115619 Active, not recruiting Hoffmann-La Roche 2020-05-30
NCT03088917 ‘Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat’ https://ClinicalTrials.gov/show/NCT03088917 Completed Radboud University 2019-12-01
NCT03059420 Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies https://ClinicalTrials.gov/show/NCT03059420 Recruiting Boston Children’s Hospital 2022-01-31
NCT03056612 Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study https://ClinicalTrials.gov/show/NCT03056612 Completed European Foundation for Study of Chronic Liver Failure 2018-07-31
NCT03053180 Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation https://ClinicalTrials.gov/show/NCT03053180 Completed AbbVie 2017-12-18
NCT03052283 Symptom Score to Assess Abdominal Involvement in Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03052283 Recruiting University of Jena 2020-12-31
NCT03011086 Evaluation of Auto Antibodies in Oral Sub Mucous Fibrosis https://ClinicalTrials.gov/show/NCT03011086 Completed Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre 2017-11-30
NCT03001388 Longitudinal Assessment of Transient Elastography in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03001388 Active, not recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2022-12-31
NCT02979340 MRI to Characterize and Predict CF Liver Disease in PUSH Cohort https://ClinicalTrials.gov/show/NCT02979340 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2019-12-31
NCT02983968 Use of the French Healthcare Insurance Database https://ClinicalTrials.gov/show/NCT02983968 Recruiting Centre Hospitalier Universitaire, Amiens 2018-09-30
NCT02938910 Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism https://ClinicalTrials.gov/show/NCT02938910 Completed Assistance Publique - Hôpitaux de Paris 2014-10-31
NCT02932657 Perceived Impact of Art Therapy in Patients With Cystic Fibrosis and in Professional Interdisciplinary Teams Taking Care of Them. https://ClinicalTrials.gov/show/NCT02932657 Completed Nantes University Hospital 2018-01-28
NCT02931812 Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation https://ClinicalTrials.gov/show/NCT02931812 Recruiting University of Burgundy 2020-05-31
NCT02926261 Methods for Nutritional Assessment in Cirrhosis https://ClinicalTrials.gov/show/NCT02926261 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2020-12-31
NCT02917408 Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital https://ClinicalTrials.gov/show/NCT02917408 Completed West China Hospital 2017-01-31
NCT02874703 Mechanisms of Diastolic Dysfunction Among Persons With HIV Compared With Non-HIV Control Subjects https://ClinicalTrials.gov/show/NCT02874703 Completed Massachusetts General Hospital 2019-08-31
NCT02853175 Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02853175 Completed Hôpital Haut-Lévêque 2018-05-31
NCT02848560 Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI https://ClinicalTrials.gov/show/NCT02848560 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-12-31
NCT02847208 Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02847208 Completed Hospices Civils de Lyon 2014-12-31
NCT02832479 Costs of Care and Adherence to Treatment for Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02832479 Completed Hospices Civils de Lyon 2016-02-29
NCT02818712 Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up https://ClinicalTrials.gov/show/NCT02818712 Active, not recruiting University of Aarhus 2021-03-31
NCT02821130 Orkambi Exercise Study https://ClinicalTrials.gov/show/NCT02821130 Active, not recruiting University of British Columbia 2019-12-31
NCT02806011 Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study https://ClinicalTrials.gov/show/NCT02806011 Enrolling by invitation Pharmicell Co., Ltd. 2021-12-31
NCT02807415 ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor https://ClinicalTrials.gov/show/NCT02807415 Recruiting Hannover Medical School 2019-09-30
NCT02803944 Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years https://ClinicalTrials.gov/show/NCT02803944 Completed Hospices Civils de Lyon 2015-09-30
NCT02803580 IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02803580 Completed Boehringer Ingelheim 2018-05-15
NCT02797912 LBM & Lung Function in Adolescents With CF https://ClinicalTrials.gov/show/NCT02797912 Completed King’s College Hospital NHS Trust 2017-08-31
NCT02790008 Magnetic Resonance Imaging and Fibrosis https://ClinicalTrials.gov/show/NCT02790008 Recruiting Linkoeping University 2019-12-31
NCT02776098 Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance https://ClinicalTrials.gov/show/NCT02776098 Active, not recruiting Children’s Hospital of Philadelphia 2020-12-31
NCT02778750 Evaluation Of The Pan-microbiome and Host Immune Response in CF https://ClinicalTrials.gov/show/NCT02778750 Recruiting NYU Langone Health 2023-11-30
NCT02755441 Early Diagnosis of Pulmonary Fibrosis - Use of Biomarkers in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02755441 Recruiting University Hospital, Gentofte, Copenhagen 2022-12-31
NCT01470547 Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry https://ClinicalTrials.gov/show/NCT01470547 Completed University of Roma La Sapienza 2017-04-30
NCT02737345 Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver Failure https://ClinicalTrials.gov/show/NCT02737345 Completed University of Utah 2017-04-01
NCT02722057 A Study to Confirm the Long-term Safety and Effectiveness of Kalydeco in Patients With Cystic Fibrosis Who Have an R117H-CFTR Mutation, Including Pediatric Patients https://ClinicalTrials.gov/show/NCT02722057 Completed Vertex Pharmaceuticals Incorporated 2019-12-31
NCT02710383 Biomarker for Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02710383 Recruiting Centogene AG Rostock 2023-12-31
NCT02693431 Impact of Art Therapy on Anxiety Identified During Hospitalizations Among Children With Cystic Fibrosis Aged 8 to 13 https://ClinicalTrials.gov/show/NCT02693431 Completed Nantes University Hospital 2018-11-27
NCT02684422 Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF) https://ClinicalTrials.gov/show/NCT02684422 Recruiting University of North Carolina, Chapel Hill 2020-12-31
NCT02699879 Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT02699879 Completed Hoffmann-La Roche 2016-09-15
NCT02670031 REMODEL: Hypertensive Heart Disease https://ClinicalTrials.gov/show/NCT02670031 Recruiting National Heart Centre Singapore 2021-09-30
NCT02639897 Evaluation of Functional Dimensions of Macintosh Laryngoscope Blade During Direct Laryngoscopy in Patients With Normal Mouth Opening https://ClinicalTrials.gov/show/NCT02639897 Recruiting Sir Ganga Ram Hospital 2020-06-30
NCT02632123 Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02632123 Recruiting Lawson Health Research Institute 2023-12-31
NCT02622477 Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone) https://ClinicalTrials.gov/show/NCT02622477 Completed Hoffmann-La Roche 2016-12-31
NCT02607722 All-Case Surveillance of Ofev in Patients With IPF in Japan https://ClinicalTrials.gov/show/NCT02607722 Recruiting Boehringer Ingelheim 2023-06-30
NCT02606487 Hyperpolarized Xenon MRI in Cystic Fibrosis Pulmonary Exacerbations https://ClinicalTrials.gov/show/NCT02606487 Completed The Hospital for Sick Children 2017-11-30
NCT02593799 Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study https://ClinicalTrials.gov/show/NCT02593799 Completed General Hospital of Shenyang Military Region 2018-12-31
NCT00001223 Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders https://ClinicalTrials.gov/show/NCT00001223 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03047031 Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03047031 Recruiting Boehringer Ingelheim 2021-12-31
NCT02569229 Glucose Tolerance in Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02569229 Active, not recruiting University Hospital, Basel, Switzerland 2018-09-30
NCT00001971 Evaluation of Patients With Liver Disease https://ClinicalTrials.gov/show/NCT00001971 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02564393 Induction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02564393 Completed University Hospital, Tours 2013-05-31
NCT02562911 Puberty in Girls Followed for Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02562911 Completed University Hospital, Toulouse 2015-12-31
NCT02558127 Asthma With Hypersecretion-associated Gene for Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02558127 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2016-02-29
NCT03795363 Orkambi Treatment in 2 to 5 Year Old Children With CF https://ClinicalTrials.gov/show/NCT03795363 Active, not recruiting Children’s Hospital of Philadelphia 2021-06-30
NCT02552849 Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada https://ClinicalTrials.gov/show/NCT02552849 Completed Hoffmann-La Roche 2017-08-15
NCT02542020 Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis https://ClinicalTrials.gov/show/NCT02542020 Recruiting Oswaldo Cruz Foundation 2020-05-31
NCT02534805 Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis https://ClinicalTrials.gov/show/NCT02534805 Completed Virginia Commonwealth University 2017-01-31
NCT02530736 Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02530736 Completed Royal Brompton & Harefield NHS Foundation Trust 2016-10-17
NCT02524704 Electrical Impedance Imaging of Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02524704 Completed Colorado State University 2016-12-31
NCT02513615 Epigenetic Determinants of Peritoneal Fibrosis https://ClinicalTrials.gov/show/NCT02513615 Completed McMaster University 2018-12-31
NCT02480270 Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation https://ClinicalTrials.gov/show/NCT02480270 Completed University of Colorado, Denver 2017-01-04
NCT02484534 Thrombin Generation Test in Patient With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02484534 Completed HaEmek Medical Center, Israel 2015-12-09
NCT02477319 A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT) https://ClinicalTrials.gov/show/NCT02477319 Completed University of Alabama at Birmingham 2018-04-25
NCT02464267 Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation in CF https://ClinicalTrials.gov/show/NCT02464267 Completed University of Zurich 2017-09-30
NCT02445157 Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02445157 Completed Royal Brompton & Harefield NHS Foundation Trust 2015-08-31
NCT02445053 Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study) https://ClinicalTrials.gov/show/NCT02445053 Active, not recruiting Vertex Pharmaceuticals Incorporated 2020-12-31
NCT02437448 Breath Analysis in Lung Fibrosis https://ClinicalTrials.gov/show/NCT02437448 Active, not recruiting University of Zurich 2020-10-31
NCT02436278 The Predictive Ability of 4MGS in IPF https://ClinicalTrials.gov/show/NCT02436278 Completed Royal Brompton & Harefield NHS Foundation Trust 2017-10-20
NCT02417740 Natural History of Noncirrhotic Portal Hypertension https://ClinicalTrials.gov/show/NCT02417740 Recruiting National Institutes of Health Clinical Center (CC) 2029-09-04
NCT02400216 Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis https://ClinicalTrials.gov/show/NCT02400216 Completed National Institutes of Health Clinical Center (CC) 2017-02-24
NCT02389127 Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02389127 Completed University of Arkansas 2017-06-01
NCT02378454 Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children https://ClinicalTrials.gov/show/NCT02378454 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2015-04-30
NCT02368080 Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults https://ClinicalTrials.gov/show/NCT02368080 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2013-12-31
NCT02363764 The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT02363764 Completed Universitair Ziekenhuis Brussel 2016-08-31
NCT02348814 Development of a Novel Biomarker for Liver Fibrosis https://ClinicalTrials.gov/show/NCT02348814 Completed University of California, Los Angeles 2019-01-26
NCT02353767 Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02353767 Completed Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba 2013-02-28
NCT02344680 Liver Fibrosis in Zambian HIV-HBV Co-infected Patients https://ClinicalTrials.gov/show/NCT02344680 Active, not recruiting University of Alabama at Birmingham 2024-08-31
NCT02335580 Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02335580 Recruiting General Hospital of Shenyang Military Region 2020-12-31
NCT02335073 Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02335073 Completed General Hospital of Shenyang Military Region 2016-06-30
NCT02316587 Assessment of Myocardial Fibrosis in Aortic STenosis https://ClinicalTrials.gov/show/NCT02316587 Completed Odense University Hospital 2016-01-31
NCT02313649 ShearWaveâ„¢ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B https://ClinicalTrials.gov/show/NCT02313649 Completed SuperSonic Imagine 2016-04-30
NCT02305784 Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT02305784 Completed Institut de Recherches Cliniques de Montreal 2018-06-01
NCT02270476 Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening https://ClinicalTrials.gov/show/NCT02270476 Recruiting Heidelberg University 2021-12-31
NCT02229994 Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases https://ClinicalTrials.gov/show/NCT02229994 Completed Assistance Publique - Hôpitaux de Paris 2014-03-27
NCT02225899 BioEnergetics and Metabolomics in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02225899 Completed Emory University 2018-11-07
NCT02211235 Glycemic Monitoring in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02211235 Active, not recruiting University of Colorado, Denver 2020-12-31
NCT02203084 Social Determinants in Chronic Disease in British Columbia https://ClinicalTrials.gov/show/NCT02203084 Completed University of British Columbia 2017-06-01
NCT02198079 A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida https://ClinicalTrials.gov/show/NCT02198079 Completed University of Miami 2015-03-31
NCT02188758 Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment https://ClinicalTrials.gov/show/NCT02188758 Completed Dartmouth-Hitchcock Medical Center 2017-12-31
NCT02181452 Liver Fibrosis Assessment With ShearWave Elastography https://ClinicalTrials.gov/show/NCT02181452 Completed SuperSonic Imagine 2014-06-30
NCT02179710 Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study https://ClinicalTrials.gov/show/NCT02179710 Completed Landon Pediatric Foundation 2016-09-30
NCT02174471 Regression of Myocardial Fibrosis After Aortic Valve Replacement https://ClinicalTrials.gov/show/NCT02174471 Completed University College, London 2015-12-31
NCT02174367 An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis https://ClinicalTrials.gov/show/NCT02174367 Active, not recruiting King’s College London 2017-07-31
NCT02163512 Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites https://ClinicalTrials.gov/show/NCT02163512 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2018-05-31
NCT02151435 Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02151435 Completed University of Michigan 2017-07-31
NCT02132351 Hepatic Fibrosis Non-invasive Methods Questionnaire https://ClinicalTrials.gov/show/NCT02132351 Completed Al-Azhar University 2016-04-30
NCT02128711 Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens https://ClinicalTrials.gov/show/NCT02128711 Recruiting University of Minnesota 2020-07-31
NCT02109822 Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF https://ClinicalTrials.gov/show/NCT02109822 Completed University of Washington 2015-06-30
NCT02090699 MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent Anemias https://ClinicalTrials.gov/show/NCT02090699 Completed University Health Network, Toronto 2014-05-31
NCT02073409 PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis https://ClinicalTrials.gov/show/NCT02073409 Recruiting National Jewish Health 2023-03-31
NCT02069457 Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02069457 Completed Beijing Friendship Hospital 2014-06-30
NCT01306279 The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective https://ClinicalTrials.gov/show/NCT01306279 Completed Imperial College London 2012-08-31
NCT01306110 Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study https://ClinicalTrials.gov/show/NCT01306110 Completed Association HGE CHU Bordeaux Sud 2010-12-31
NCT01300390 Assessment of Endothelial Function, Apolipoproteins and Adiponectin https://ClinicalTrials.gov/show/NCT01300390 Completed Mayo Clinic 2015-10-31
NCT01285895 Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT01285895 Completed Nantes University Hospital 2013-10-31
NCT02056132 Breath Condensate Study in Patients With Cystic Fibrosis. https://ClinicalTrials.gov/show/NCT02056132 Recruiting University of Florida 2020-04-30
NCT02023190 Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation https://ClinicalTrials.gov/show/NCT02023190 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2020-12-31
NCT02023177 Phase Angle and Mortality in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02023177 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2013-07-31
NCT02055222 Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease https://ClinicalTrials.gov/show/NCT02055222 Completed National Institutes of Health Clinical Center (CC) 2018-08-23
NCT03360032 Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF https://ClinicalTrials.gov/show/NCT03360032 Recruiting University Hospitals Coventry and Warwickshire NHS Trust 2020-04-30
NCT02047240 Renal Function Determination in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02047240 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2015-12-31
NCT02044523 Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound https://ClinicalTrials.gov/show/NCT02044523 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2018-06-30
NCT02039986 Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF) https://ClinicalTrials.gov/show/NCT02039986 Completed Children’s Hospital of Philadelphia 2016-10-11
NCT00084305 Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00084305 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03357913 Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03357913 Completed Hospices Civils de Lyon 2017-06-01
NCT03478553 Genetics of IPF - Screening Study for Family Members https://ClinicalTrials.gov/show/NCT03478553 Recruiting University of Colorado, Denver 2021-09-29
NCT02007746 Liver Fibrosis in Sickle Cell Disease https://ClinicalTrials.gov/show/NCT02007746 Active, not recruiting University of Miami 2018-12-31
NCT02009293 The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02009293 Completed Erasmus Medical Center 2016-12-31
NCT02003079 Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02003079 Completed St. Paul’s Hospital, Canada 2014-03-31
NCT01988753 Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases https://ClinicalTrials.gov/show/NCT01988753 Completed Baylor College of Medicine 2016-06-30
NCT01983787 Pharmacokinetics of Piperacillin, Given as Continuous Infusion to Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01983787 Completed University of Aarhus 2015-06-30
NCT01975259 Investigating the Incretin Effect in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01975259 Completed Liverpool Heart and Chest Hospital NHS Foundation Trust 2015-07-31
NCT01973192 Viral Pathogenesis of Early Cystic Fibrosis Lung Disease https://ClinicalTrials.gov/show/NCT01973192 Completed Indiana University 2016-12-01
NCT02025829 IL-17 Neutrophils in CF Lung Inflammation https://ClinicalTrials.gov/show/NCT02025829 Completed University Hospitals Cleveland Medical Center 2014-12-31
NCT01944878 The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient https://ClinicalTrials.gov/show/NCT01944878 Completed Chuncheon Sacred Heart Hospital 2013-08-31
NCT01929174 Diffuse Myocardial Fibrosis in Fontan Patients https://ClinicalTrials.gov/show/NCT01929174 Completed Oregon Health and Science University 2016-05-01
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01883037 Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT https://ClinicalTrials.gov/show/NCT01883037 Completed Royal Brompton & Harefield NHS Foundation Trust 2014-04-30
NCT01872793 Validation of BIVA for Nutritional Assessment in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01872793 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2016-07-31
NCT01872767 Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure https://ClinicalTrials.gov/show/NCT01872767 Completed Institute of Liver and Biliary Sciences, India 2014-11-30
NCT01863238 An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01863238 Completed Vertex Pharmaceuticals Incorporated 2016-05-31
NCT01858519 Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy https://ClinicalTrials.gov/show/NCT01858519 Completed AbbVie 2016-09-30
NCT01851642 Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs https://ClinicalTrials.gov/show/NCT01851642 Recruiting University of Florida 2020-09-30
NCT01848392 Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients. https://ClinicalTrials.gov/show/NCT01848392 Completed Assistance Publique - Hôpitaux de Paris 2014-07-30
NCT01837160 Angiogenesis and Fibrosis in Aortic Stenosis https://ClinicalTrials.gov/show/NCT01837160 Completed University of Edinburgh 2015-08-31
NCT01832519 Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF https://ClinicalTrials.gov/show/NCT01832519 Completed Children’s Hospital Medical Center, Cincinnati 2017-01-09
NCT03350828 CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes https://ClinicalTrials.gov/show/NCT03350828 Recruiting Seattle Children’s Hospital 2021-01-01
NCT01825538 Assessment of Pulmonary Specialty Physicians’ Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases https://ClinicalTrials.gov/show/NCT01825538 Completed Ohio State University 2014-06-30
NCT01815866 Cough-Generated Aerosols of NTM in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01815866 Completed University of Florida 2015-07-31
NCT01813045 Angiogenesis and Fibrosis in Myocardial Infarction https://ClinicalTrials.gov/show/NCT01813045 Completed University of Edinburgh 2016-03-31
NCT01806025 Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT01806025 Completed Carmel Medical Center 2015-01-31
NCT01799642 Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01799642 Completed University of British Columbia 2014-12-31
NCT01792440 The Sputum Colour Chart as a Predictor of Lung Inflammation and Proteolysis in Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01792440 Completed Universitaire Ziekenhuizen Leuven 2010-07-31
NCT01792427 Mortality in Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01792427 Completed Universitaire Ziekenhuizen Leuven 2012-10-31
NCT01777373 Conducting Airways in Lung Fibrosis (VACFI) https://ClinicalTrials.gov/show/NCT01777373 Completed Assistance Publique - Hôpitaux de Paris 2015-01-31
NCT01755936 The Role of Myocardial Fibrosis in Patients With Aortic Stenosis https://ClinicalTrials.gov/show/NCT01755936 Completed University of Edinburgh 2016-01-31
NCT01751191 HVPG for Rebleeding Risk Stratification https://ClinicalTrials.gov/show/NCT01751191 Completed Hospital Clinic of Barcelona 2012-11-30
NCT01736839 Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution https://ClinicalTrials.gov/show/NCT01736839 Completed National Jewish Health 2017-07-27
NCT01729611 Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01729611 Recruiting The Cleveland Clinic 2021-03-31
NCT01701687 Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT01701687 Completed University of Nottingham 2015-07-31
NCT01695408 Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT01695408 Recruiting Technische Universität Dresden 2020-04-30
NCT01695083 Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients https://ClinicalTrials.gov/show/NCT01695083 Completed Assistance Publique - Hôpitaux de Paris 2015-11-30
NCT01687946 Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology https://ClinicalTrials.gov/show/NCT01687946 Completed Medical University of Vienna 2013-12-31
NCT01666626 Ultrasound Stiffness Imaging in Crohn’s Disease https://ClinicalTrials.gov/show/NCT01666626 Completed University of Michigan 2015-07-31
NCT01651455 Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000 https://ClinicalTrials.gov/show/NCT01651455 Completed Chiesi Farmaceutici S.p.A. 2013-03-31
NCT01652157 Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy) https://ClinicalTrials.gov/show/NCT01652157 Recruiting AbbVie 2022-07-29
NCT01636219 Cough Efficiency in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01636219 Completed Sheba Medical Center 2013-06-30
NCT01626157 A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF) https://ClinicalTrials.gov/show/NCT01626157 Completed National Jewish Health 2018-01-31
NCT01616862 The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01616862 Completed State University of New York - Upstate Medical University 2013-06-30
NCT01603953 Bioelectrical Impedance Vector Analysis in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01603953 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2013-12-31
NCT01578226 Procalcitonin in Cirrhotic Patients at High Risk for Sepsis https://ClinicalTrials.gov/show/NCT01578226 Completed University of Modena and Reggio Emilia 2010-09-30
NCT01573325 HRQoL in the Low MELD Pre-tx Population https://ClinicalTrials.gov/show/NCT01573325 Completed Northwestern University 2012-07-31
NCT01572870 Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients https://ClinicalTrials.gov/show/NCT01572870 Completed Rambam Health Care Campus 2011-03-31
NCT01569880 Pre-flight Evaluation of Adult Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01569880 Completed Oslo University Hospital 2008-12-31
NCT01549314 Cystic Fibrosis Related Bone Disease: the Role of CFTR https://ClinicalTrials.gov/show/NCT01549314 Completed Massachusetts General Hospital 2018-05-31
NCT01524562 HIV Accelerated Liver Disease in Uganda https://ClinicalTrials.gov/show/NCT01524562 Completed National Institutes of Health Clinical Center (CC) 2015-05-12
NCT01521338 G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) https://ClinicalTrials.gov/show/NCT01521338 Active, not recruiting University of Alabama at Birmingham 2021-01-31
NCT01501578 Pulmonary Fibrosis and Telomerase Mutation Study https://ClinicalTrials.gov/show/NCT01501578 Completed Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 2012-06-30
NCT01479166 Bronchial Inflammation of Small Airways in Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01479166 Completed Johann Wolfgang Goethe University Hospital 2012-05-31
NCT01469962 Evaluation of Liver Fibrosis Following Surgical-induced Weight Loss https://ClinicalTrials.gov/show/NCT01469962 Completed University Hospital, Rouen 2013-02-28
NCT01460836 Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01460836 Completed Novartis 2010-10-31
NCT01433302 Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass https://ClinicalTrials.gov/show/NCT01433302 Completed M.D. Anderson Cancer Center 2014-03-31
NCT01401998 UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource https://ClinicalTrials.gov/show/NCT01401998 Recruiting Children’s National Research Institute 2022-09-30
NCT01401439 Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01401439 Completed University of Arkansas 2016-07-31
NCT01375036 Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT01375036 Completed Gilead Sciences 2016-12-31
NCT01361061 AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver https://ClinicalTrials.gov/show/NCT01361061 Completed University Hospital Freiburg 2015-11-30
NCT01353950 Costimulatory Molecules as Biomarkers in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01353950 Completed Oregon Health and Science University 2013-06-30
NCT01343524 Changes in Lung Function Based on Differences in Spirometry Equipment Used in Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01343524 Completed State University of New York - Upstate Medical University 2010-12-31
NCT01331980 Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls https://ClinicalTrials.gov/show/NCT01331980 Completed University of Arkansas 2015-07-31
NCT04442711 Cohort of IPF Patients Experiencing an Exacerbation https://ClinicalTrials.gov/show/NCT04442711 Recruiting University Hospital, Gentofte, Copenhagen 2022-06-01
NCT04430491 To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT04430491 Completed Maastricht University 2017-01-01
NCT04400955 A Study of Web and Tablet-based Interactive Audiometry in Adults With CF https://ClinicalTrials.gov/show/NCT04400955 Completed Royal Brompton & Harefield NHS Foundation Trust 2019-03-01
NCT04397809 Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04397809 Active, not recruiting National Jewish Health 2019-05-23
NCT04389593 Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference https://ClinicalTrials.gov/show/NCT04389593 Recruiting University of California, San Diego 2020-12-31
NCT04371042 PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies https://ClinicalTrials.gov/show/NCT04371042 Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2035-12-31
NCT04354038 Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations https://ClinicalTrials.gov/show/NCT04354038 Recruiting National Jewish Health 2025-12-31
NCT04352309 Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04352309 Recruiting AbbVie 2021-04-20
NCT04332484 Global Coagulation Assessment in Cirrhosis and ACLF https://ClinicalTrials.gov/show/NCT04332484 Completed Postgraduate Institute of Medical Education and Research 2019-08-31
NCT04341532 Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations https://ClinicalTrials.gov/show/NCT04341532 Recruiting National Jewish Health 2023-12-31
NCT04316780 Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes https://ClinicalTrials.gov/show/NCT04316780 Enrolling by invitation Steward St. Elizabeth’s Medical Center of Boston, Inc. 2019-12-31
NCT04314323 National Registry of IRPF in China https://ClinicalTrials.gov/show/NCT04314323 Recruiting Peking Union Medical College Hospital 2030-03-31
NCT04306939 Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study https://ClinicalTrials.gov/show/NCT04306939 Recruiting University of Pittsburgh 2025-12-01
NCT04301856 Response to CFTR Modulators in CF Patients Under 18 Years https://ClinicalTrials.gov/show/NCT04301856 Recruiting Societe Francaise de la Mucoviscidose 2025-07-01
NCT04302428 Zinc Status and Growth in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04302428 Recruiting Indiana University 2021-06-30
NCT04264754 Characterization of Methylation Patterns in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04264754 Recruiting Nucleix Ltd. 2024-12-31
NCT04267406 ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal Hypertension https://ClinicalTrials.gov/show/NCT04267406 Completed Ataturk University 2019-10-30
NCT04257630 Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD https://ClinicalTrials.gov/show/NCT04257630 Recruiting Schön Klinik Berchtesgadener Land 2022-03-31
NCT04256772 Anti-IL5 and Other Biotherapies in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04256772 Recruiting University Hospital, Montpellier 2020-06-01
NCT04235166 Risk Assessment After Acute Upper Gastrointestinal Haemorrhage in Cirrhosis https://ClinicalTrials.gov/show/NCT04235166 Recruiting Affiliated Hospital to Academy of Military Medical Sciences 2020-05-31
NCT04221347 Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC https://ClinicalTrials.gov/show/NCT04221347 Recruiting Military University Hospital, Prague 2020-12-31
NCT04217889 Cystic Fibrosis Adherence Study https://ClinicalTrials.gov/show/NCT04217889 Recruiting Hospices Civils de Lyon 2020-07-31
NCT04199910 4beta-hydroxycholesterol in Cirrhosis https://ClinicalTrials.gov/show/NCT04199910 Recruiting University of Oulu 2021-12-31
NCT04179773 Chemotherapy and Liver Cirrhosis in Frequently-associated Cancers https://ClinicalTrials.gov/show/NCT04179773 Recruiting University Hospital, Lille 2025-01-31
NCT04177251 Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT04177251 Recruiting San Gerardo Hospital 2020-12-31
NCT04174664 Comparison of Different Functional Capacity Tests in Cystic Fibrosis Patients With Acute Pulmonary Exacerbation https://ClinicalTrials.gov/show/NCT04174664 Recruiting Hacettepe University 2021-01-01
NCT04171583 Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways https://ClinicalTrials.gov/show/NCT04171583 Recruiting University Hospital Muenster 2020-05-31
NCT04161313 Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children https://ClinicalTrials.gov/show/NCT04161313 Completed Bezmialem Vakif University 2020-02-24
NCT04160897 Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT04160897 Enrolling by invitation Ruijin Hospital 2020-10-31
NCT04157361 Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis. https://ClinicalTrials.gov/show/NCT04157361 Recruiting The Institute of Molecular and Translational Medicine, Czech Republic 2020-01-31
NCT04153266 Oral Epithelial Dysplasia Informational Needs Questionnaire https://ClinicalTrials.gov/show/NCT04153266 Completed University College, London 2019-12-21
NCT03819400 Evaluation of Kidney Graft’s Fibrosis With Real Time Shear-wave Elastography https://ClinicalTrials.gov/show/NCT03819400 Recruiting University Hospital, Tours 2020-08-31
NCT04148157 Quality of Life in IPF - Patient and Physician Perceptions https://ClinicalTrials.gov/show/NCT04148157 Recruiting University of Washington 2020-03-01
NCT04138589 Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function https://ClinicalTrials.gov/show/NCT04138589 Recruiting University Medical Center Groningen 2021-02-01
NCT04119115 Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT04119115 Recruiting William Beaumont Hospitals 2021-02-28
NCT04111120 Heparin Like Effect in Acute Variceal Bleeding https://ClinicalTrials.gov/show/NCT04111120 Recruiting Postgraduate Institute of Medical Education and Research 2020-12-31
NCT04076631 Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04076631 Recruiting Tongji Hospital 2020-09-30
NCT04057287 Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC) https://ClinicalTrials.gov/show/NCT04057287 Recruiting Institute of Liver and Biliary Sciences, India 2021-06-30
NCT04058327 A Study of MHE in Patients With Liver Diseases https://ClinicalTrials.gov/show/NCT04058327 Recruiting Tongji Hospital 2020-06-30
NCT04044248 TIPS Plus Transvenous Obliteration for Gastric Varices https://ClinicalTrials.gov/show/NCT04044248 Recruiting University of Illinois at Chicago 2021-04-04
NCT04036357 Liver Damage and Cardiometabolic Disorders in NAFLD https://ClinicalTrials.gov/show/NCT04036357 Recruiting University of Roma La Sapienza 2036-12-31
NCT04038710 Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease. https://ClinicalTrials.gov/show/NCT04038710 Active, not recruiting National Jewish Health 2021-02-28
NCT04031690 Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis Patients https://ClinicalTrials.gov/show/NCT04031690 Recruiting Centre Hospitalier Universitaire Dijon 2021-10-31
NCT04019080 Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden https://ClinicalTrials.gov/show/NCT04019080 Recruiting Karolinska University Hospital 2021-12-31
NCT04026360 Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04026360 Recruiting University Hospital Inselspital, Berne 2050-08-31
NCT04016194 Prediction of Survival in Children With Cystic Fibrosis Using the Multiple-breath Washout https://ClinicalTrials.gov/show/NCT04016194 Completed University Hospital Inselspital, Berne 2005-12-31
NCT04016571 Parameters to Assess Response to Intra-Venous Antibiotic Treatment for Pulmonary Exacerbations in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04016571 Recruiting Belfast Health and Social Care Trust 2019-09-30
NCT04016168 Idiopathic Pulmonary Fibrosis and Serum Bank https://ClinicalTrials.gov/show/NCT04016168 Recruiting Rennes University Hospital 2019-10-22
NCT03990753 Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901) https://ClinicalTrials.gov/show/NCT03990753 Recruiting Nanfang Hospital of Southern Medical University 2020-06-12
NCT03979417 Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets https://ClinicalTrials.gov/show/NCT03979417 Recruiting Institut Pasteur 2022-09-01
NCT03965260 Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT03965260 Recruiting Hospices Civils de Lyon 2020-01-31
NCT03958071 A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking https://ClinicalTrials.gov/show/NCT03958071 Completed Boehringer Ingelheim 2019-05-31
NCT03961516 Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03961516 Recruiting University Hospitals Cleveland Medical Center 2020-07-01
NCT03948659 Ventriculo-arterial Coupling in Cirrhotics https://ClinicalTrials.gov/show/NCT03948659 Completed Hospices Civils de Lyon 2019-04-30
NCT03944928 ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution https://ClinicalTrials.gov/show/NCT03944928 Recruiting University Hospital, Tours 2022-06-30
NCT03919604 ECMO for Lung Transplantation in Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT03919604 Completed Policlinico Hospital 2018-12-31
NCT03919032 Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics https://ClinicalTrials.gov/show/NCT03919032 Completed Hospital Italiano de Buenos Aires 2019-12-31
NCT03910920 Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center. https://ClinicalTrials.gov/show/NCT03910920 Enrolling by invitation Queen Fabiola Children’s University Hospital 2021-01-31
NCT03905746 Study of microRNAs in a Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT03905746 Recruiting Hospices Civils de Lyon 2021-06-26
NCT03898284 Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03898284 Recruiting University Hospital, Tours 2021-12-31
NCT03902236 Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis https://ClinicalTrials.gov/show/NCT03902236 Recruiting Hacettepe University 2019-10-07
NCT03896607 Liver and the Spleen Stifness in Adult Patients With Gaucher’s Disease Using Ultrasound Shear Wave Elastography https://ClinicalTrials.gov/show/NCT03896607 Recruiting HaEmek Medical Center, Israel 2021-02-01
NCT03892304 Gynecological Health Improvement of Adult Women With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03892304 Completed Hospices Civils de Lyon 2017-12-31
NCT03884062 Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals https://ClinicalTrials.gov/show/NCT03884062 Completed Egyptian Liver Hospital 2018-06-01
NCT03886350 Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk) https://ClinicalTrials.gov/show/NCT03886350 Recruiting University Hospital, Tours 2022-04-30
NCT03878563 Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC) https://ClinicalTrials.gov/show/NCT03878563 Recruiting Spital Limmattal Schlieren 2020-11-20
NCT03862235 Decreased T1 Times and Impaired Myocardial Contractility in Anabolic Androgenic Steroids Users https://ClinicalTrials.gov/show/NCT03862235 Completed University of Sao Paulo General Hospital 2016-04-01
NCT03857633 MRI Assessment of Myocardial Fibrosis Associated With Monocyte Phenotype in End Stage Renal Failure https://ClinicalTrials.gov/show/NCT03857633 Recruiting Imperial College London 2021-02-01
NCT03859531 Gastrointestinal Study at Orkambi Therapy in CF Patients https://ClinicalTrials.gov/show/NCT03859531 Recruiting Karolinska University Hospital 2020-06-30
NCT03853629 Air Pollution and Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03853629 Completed Queen Mary University of London 2020-01-30
NCT03839992 Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03839992 Recruiting Gelb, Arthur F., M.D. 2020-04-25
NCT03837444 Microvesicles and Monocytes to Predict Mortality of Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03837444 Recruiting Assistance Publique - Hôpitaux de Paris 2021-04-15
NCT03850145 Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT03850145 Completed University Hospital, Montpellier 2019-12-01
NCT03801993 Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03801993 Completed Seattle Children’s Hospital 2019-09-17
NCT03804593 HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03804593 Completed Epigenomics, Inc 2019-10-01
NCT03770845 Nutritional Assessment in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03770845 Recruiting San Gerardo Hospital 2020-06-30
NCT03778775 Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801) https://ClinicalTrials.gov/show/NCT03778775 Recruiting Nanfang Hospital of Southern Medical University 2019-10-13
NCT03754088 In Vitro Model of the Cystic Fibrosis Bronchial Epithelium Via iPS Technology https://ClinicalTrials.gov/show/NCT03754088 Completed University Hospital, Montpellier 2019-04-25
NCT03753828 Estimated Impact of Fungal Colonization in Cystic Fibrosis From Secondary Exploitation of MucoFong Database. https://ClinicalTrials.gov/show/NCT03753828 Completed University Hospital, Bordeaux 2018-10-13
NCT03749954 Magnetically Controlled Capsule Endoscopy for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (CHESS1801) https://ClinicalTrials.gov/show/NCT03749954 Recruiting Nanfang Hospital of Southern Medical University 2019-11-08
NCT03746210 Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03746210 Recruiting University Hospital, Bonn 2025-12-31
NCT03743272 Repeatability and Reproducibility of Multiparametric MRI https://ClinicalTrials.gov/show/NCT03743272 Recruiting Perspectum Diagnostics Ltd 2020-05-17
NCT03736096 Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT03736096 Recruiting University Hospital, Brest 2019-10-31
NCT03732872 Epithelial Mesenchymal Transition Markers in OSMF https://ClinicalTrials.gov/show/NCT03732872 Completed The Oxford Dental College, Hospital and Research Center, Bangalore, India 2017-12-28
NCT03726827 A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations https://ClinicalTrials.gov/show/NCT03726827 Completed Fatty liver Foundation 2019-08-30
NCT03713437 Measurement of Beta Cell Death in Individuals With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03713437 Recruiting University of Nebraska 2020-06-30
NCT03711435 Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics https://ClinicalTrials.gov/show/NCT03711435 Completed Xuzhou Traditional Chinese Medicine Hospital 2020-02-05
NCT03689426 Using Cardiovascular Magnetic Resonance Tissue Characterisation and Wearable Technology to PREDICT Clinical Outcomes, Response to Therapy and Arrhythmias in Hospitalised Heart Failure Patients https://ClinicalTrials.gov/show/NCT03689426 Recruiting University Hospital Southampton NHS Foundation Trust 2021-04-30
NCT03684759 Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03684759 Completed University Hospital, Brest 2017-02-06
NCT03674216 Study of Peripherally Inserted Venous Catheters in Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT03674216 Recruiting Maine Medical Center 2021-12-31
NCT03670472 Correction of Nonsense Mutations in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03670472 Recruiting University Hospital, Lille 2028-01-31
NCT03659214 Impact of the Introduction of ORKAMBI on Anxiety, Depression, Quality of Life and Adherence of Adolescents and Young Adults https://ClinicalTrials.gov/show/NCT03659214 Recruiting Assistance Publique - Hôpitaux de Paris 2018-12-31
NCT03663062 ObeSity Related Colorectal Adenoma Risk https://ClinicalTrials.gov/show/NCT03663062 Recruiting South Tyneside and Sunderland NHS Foundation Trust 2019-07-01
NCT03658551 Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy https://ClinicalTrials.gov/show/NCT03658551 Recruiting Johannes Gutenberg University Mainz 2020-08-01
NCT03652090 Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03652090 Completed Institut National de la Santé Et de la Recherche Médicale, France 2016-03-03
NCT03650660 Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist https://ClinicalTrials.gov/show/NCT03650660 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-05-31
NCT03635541 Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03635541 Recruiting Beijing Friendship Hospital 2021-02-28
NCT03607396 Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03607396 Recruiting Hospital Universitari Vall d’Hebron Research Institute 2019-07-01
NCT03602573 Liver Fibrosis in Peri-menopausal Women https://ClinicalTrials.gov/show/NCT03602573 Recruiting Chang Gung Memorial Hospital 2019-07-31
NCT03599492 The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut Microbiota https://ClinicalTrials.gov/show/NCT03599492 Recruiting NYU Langone Health 2019-12-31
NCT03590288 Dynamic Monitor of HVPG and Its Prognostic Value in Predicting Outcomes in Patients Undergoing TIPS https://ClinicalTrials.gov/show/NCT03590288 Recruiting Fourth Military Medical University 2021-06-01
NCT03588260 Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03588260 Active, not recruiting Istanbul Medipol University Hospital 2021-09-30
NCT03586518 Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients https://ClinicalTrials.gov/show/NCT03586518 Recruiting University of Leicester 2021-07-31
NCT03585933 Prognostic Value of Myocardial Fibrosis in Severe Aortic Valve Stenosis https://ClinicalTrials.gov/show/NCT03585933 Recruiting Vilnius University 2021-05-31
NCT03579173 Determinants of Early Cystic Fibrosis Lung Disease https://ClinicalTrials.gov/show/NCT03579173 Active, not recruiting Indiana University 2020-04-30
NCT03584204 Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome https://ClinicalTrials.gov/show/NCT03584204 Recruiting University Hospital, Bonn 2025-07-31
NCT03571711 Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis https://ClinicalTrials.gov/show/NCT03571711 Recruiting Hannover Medical School 2020-07-01
NCT03577756 Neurodevelopmental Assessment of Infants With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03577756 Recruiting Hacettepe University 2019-12-12
NCT03569904 Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03569904 Recruiting University Hospital, Grenoble 2021-09-30
NCT03567785 Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03567785 Recruiting KU Leuven 2021-06-30
NCT03566550 Gut Imaging for Function & Transit in Cystic Fibrosis Study 1 https://ClinicalTrials.gov/show/NCT03566550 Completed Nottingham University Hospitals NHS Trust 2019-02-20
NCT03565692 Lum-Iva-biota: Exploring the Respiratory Mycobiota and Microbiota Profile in French CF Patients Taking Lumacaftor-Ivacaftor https://ClinicalTrials.gov/show/NCT03565692 Recruiting University Hospital, Bordeaux 2023-02-28
NCT03542318 Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03542318 Completed University of Malta 2016-01-31
NCT03548597 Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery https://ClinicalTrials.gov/show/NCT03548597 Completed European Georges Pompidou Hospital 2015-01-12
NCT03539757 Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients https://ClinicalTrials.gov/show/NCT03539757 Recruiting Children’s Hospital Medical Center, Cincinnati 2023-04-30
NCT03531593 Dose Effect Relationship of MTX and IBD https://ClinicalTrials.gov/show/NCT03531593 Completed Children’s Mercy Hospital Kansas City 2018-05-31
NCT03524859 Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls. https://ClinicalTrials.gov/show/NCT03524859 Completed Universidad Católica San Antonio de Murcia 2019-03-26
NCT03513900 Non-invasive Methods to Predict PHG in Cirrhosis https://ClinicalTrials.gov/show/NCT03513900 Completed Second Affiliated Hospital of Xi’an Jiaotong University 2018-12-20
NCT03513887 Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03513887 Completed Second Affiliated Hospital of Xi’an Jiaotong University 2019-01-12
NCT03512119 Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor https://ClinicalTrials.gov/show/NCT03512119 Completed University Hospital, Strasbourg, France 2018-04-30
NCT03507140 Microbiota Study in Liver Transplanted Patients https://ClinicalTrials.gov/show/NCT03507140 Recruiting University Hospital, Grenoble 2021-11-01
NCT03508388 Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT03508388 Recruiting University Hospital, Montpellier 2020-12-31
NCT03494894 Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary Dyskinesia https://ClinicalTrials.gov/show/NCT03494894 Recruiting Centre Hospitalier Intercommunal Creteil 2019-09-01
NCT03487861 Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis https://ClinicalTrials.gov/show/NCT03487861 Recruiting Asan Medical Center 2020-12-31
NCT03483272 MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) https://ClinicalTrials.gov/show/NCT03483272 Recruiting Hvidovre University Hospital 2023-01-31
NCT03472742 An Follow-Up Study of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03472742 Recruiting Rohto Pharmaceutical Co., Ltd. 2021-07-31
NCT03462524 Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology https://ClinicalTrials.gov/show/NCT03462524 Completed St. James’s Hospital, Ireland 2016-01-01
NCT03458845 Prevalence of Sarcopenia and Undernutrition in Patients With Cirrhosis and Abdominal Hernia https://ClinicalTrials.gov/show/NCT03458845 Recruiting University of Sao Paulo 2021-03-31
NCT03457935 Detection of Early Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03457935 Recruiting Temple University 2020-12-31
NCT03446521 AGRA Before and After Liver Transplantation https://ClinicalTrials.gov/show/NCT03446521 Recruiting Medical University of Graz 2021-07-31
NCT03438916 MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03438916 Recruiting Hvidovre University Hospital 2023-04-30
NCT03437486 Mechanisms of Familial Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03437486 Recruiting Vanderbilt University Medical Center 2021-04-30
NCT03437811 Airway Clearance System (K031876) Phase IV Device Efficacy https://ClinicalTrials.gov/show/NCT03437811 Completed Mack Biotech, Corp. 2019-11-01
NCT03414398 Assessing Cirrhosis Quality of Care While Accounting for Cost https://ClinicalTrials.gov/show/NCT03414398 Recruiting New York Presbyterian Hospital 2021-01-01
NCT01241227 Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT01241227 Completed Association HGE CHU Bordeaux Sud NA
NCT01241890 Prevention of CF Exacerbation in Childhood: PREVEC Study https://ClinicalTrials.gov/show/NCT01241890 Completed Maastricht University Medical Center 2013-08-31
NCT01238081 The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults https://ClinicalTrials.gov/show/NCT01238081 Completed Manchester University NHS Foundation Trust 2012-04-30
NCT01217983 Utility of Renal Biomarkers in Cirrhosis https://ClinicalTrials.gov/show/NCT01217983 Completed University Hospital, Geneva 2012-10-31
NCT01213927 National Cohort of Uncomplicated Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT01213927 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2018-11-30
NCT01208311 Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound https://ClinicalTrials.gov/show/NCT01208311 Completed Northwell Health 2016-12-31
NCT01187173 The Fibrosis-Lymphedema Continuum in Head and Neck Cancer https://ClinicalTrials.gov/show/NCT01187173 Completed Vanderbilt University 2014-11-30
NCT01161953 Genetic Epidemiology of Primary Biliary Cirrhosis (PBC) https://ClinicalTrials.gov/show/NCT01161953 Active, not recruiting Mayo Clinic 2025-12-31
NCT01160471 Noninvasive Imaging of Heart Failure: A Pilot Study https://ClinicalTrials.gov/show/NCT01160471 Completed National Institutes of Health Clinical Center (CC) NA
NCT01151475 Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE) https://ClinicalTrials.gov/show/NCT01151475 Completed University of Aarhus 2011-08-31
NCT01150591 Microaspiration in Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT01150591 Completed University of California, San Francisco 2015-06-30
NCT01144507 Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01144507 Active, not recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2022-11-30
NCT01150136 Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study https://ClinicalTrials.gov/show/NCT01150136 Completed University of British Columbia 2009-03-31
NCT01135316 Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR https://ClinicalTrials.gov/show/NCT01135316 Completed Lantheus Medical Imaging 2013-09-30
NCT01134822 Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England) https://ClinicalTrials.gov/show/NCT01134822 Completed University of Nottingham 2017-09-05
NCT01121367 Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema https://ClinicalTrials.gov/show/NCT01121367 Completed Beijing Chao Yang Hospital 2011-06-30
NCT01113216 Genetic Modifiers of Cystic Fibrosis Related Diabetes https://ClinicalTrials.gov/show/NCT01113216 Enrolling by invitation Johns Hopkins University 2025-04-30
NCT01107028 Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT01107028 Completed National Jewish Health 2014-10-31
NCT01088217 Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT01088217 Recruiting National Jewish Health 2022-06-30
NCT01078740 Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects https://ClinicalTrials.gov/show/NCT01078740 Completed CF Therapeutics Development Network Coordinating Center 2010-07-31
NCT01071707 Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT01071707 Completed University of Michigan 2011-08-31
NCT01014754 Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels https://ClinicalTrials.gov/show/NCT01014754 Completed Northwestern University 2014-04-30
NCT00941902 A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor https://ClinicalTrials.gov/show/NCT00941902 Completed Ziv Hospital 2010-09-30
NCT00943514 Natural History of Bronchiectasis https://ClinicalTrials.gov/show/NCT00943514 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03870542 Multicenter, Prospective Study for Urinary Exosomal Biomarkers of Kidney Allograft Tubulointerstitial Fibrosis https://ClinicalTrials.gov/show/NCT03870542 Recruiting Asan Medical Center 2022-04-30
NCT00906568 Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) https://ClinicalTrials.gov/show/NCT00906568 Completed Johann Wolfgang Goethe University Hospital 2010-05-31
NCT00908830 Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients https://ClinicalTrials.gov/show/NCT00908830 Completed University of Michigan 2011-05-31
NCT00883454 Estimation of Functional Liver Reserve Using Cholinesterases https://ClinicalTrials.gov/show/NCT00883454 Completed University of Milan NA
NCT00869479 Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis https://ClinicalTrials.gov/show/NCT00869479 Completed Massachusetts General Hospital 2010-09-30
NCT00863694 Fecal Calprotectin in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00863694 Completed Medical College of Wisconsin 2013-08-31
NCT04353752 Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs https://ClinicalTrials.gov/show/NCT04353752 Recruiting National Jewish Health 2023-12-31
NCT04297709 Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04297709 Completed Mologic Ltd 2019-07-31
NCT04335370 Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04335370 Recruiting University of Michigan 2020-12-31
NCT03908294 Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents https://ClinicalTrials.gov/show/NCT03908294 Completed Johann Wolfgang Goethe University Hospital 2020-01-01
NCT03386994 OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study https://ClinicalTrials.gov/show/NCT03386994 Completed Boehringer Ingelheim 2019-09-16
NCT02958592 Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study https://ClinicalTrials.gov/show/NCT02958592 Completed Sun Yat-sen University 2016-03-31
NCT00827723 Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma https://ClinicalTrials.gov/show/NCT00827723 Completed University of Lausanne Hospitals 2018-02-28
NCT04206436 CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04206436 Enrolling by invitation Indiana University 2022-10-01
NCT04245189 EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT04245189 Recruiting Asian Institute of Gastroenterology, India 2020-10-31
NCT04168619 MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool https://ClinicalTrials.gov/show/NCT04168619 Recruiting The University of Hong Kong 2020-12-31
NCT03234387 A CFit Study - Baseline https://ClinicalTrials.gov/show/NCT03234387 Recruiting University of Portsmouth 2020-03-31
NCT02468479 Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02468479 Completed General Hospital of Shenyang Military Region 2016-12-31
NCT01810458 Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) https://ClinicalTrials.gov/show/NCT01810458 Completed University of Florida 2019-09-30
NCT01110694 Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study https://ClinicalTrials.gov/show/NCT01110694 Completed Royal Brompton & Harefield NHS Foundation Trust 2018-09-30
NCT01961362 Supplemental Oxygen in Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT01961362 Completed National Jewish Health 2016-12-31
NCT01852448 Genetics of Insulin and Incretins in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01852448 Active, not recruiting Children’s Hospital of Philadelphia 2024-07-31
NCT01674465 Role of Nox2 in CNI-induced Renal Fibrosis https://ClinicalTrials.gov/show/NCT01674465 Completed University of Wisconsin, Madison 2018-08-09
NCT01533636 CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment https://ClinicalTrials.gov/show/NCT01533636 Recruiting University of California, San Francisco 2020-04-30
NCT01379040 Volatile Organic Compounds in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01379040 Completed Landon Pediatric Foundation 2009-12-31
NCT01319253 A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies https://ClinicalTrials.gov/show/NCT01319253 Completed Indiana University 2012-07-31
NCT00804583 Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease https://ClinicalTrials.gov/show/NCT00804583 Active, not recruiting University of North Carolina, Chapel Hill 2021-07-31
NCT00804661 Sleep in Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00804661 Completed Assistance Publique - Hôpitaux de Paris 2009-06-30
NCT03074149 Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF) https://ClinicalTrials.gov/show/NCT03074149 Active, not recruiting Boehringer Ingelheim 2021-04-30
NCT00368446 Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease https://ClinicalTrials.gov/show/NCT00368446 Completed National Institutes of Health Clinical Center (CC) NA
NCT00366509 Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases https://ClinicalTrials.gov/show/NCT00366509 Completed National Institutes of Health Clinical Center (CC) NA
NCT00326482 Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00326482 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT03710824 Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib https://ClinicalTrials.gov/show/NCT03710824 Recruiting Boehringer Ingelheim 2022-03-28
NCT02630940 Exhaled Breath Condensate Biomarkers and Cough in IPF https://ClinicalTrials.gov/show/NCT02630940 Completed University of East Anglia 2016-06-30
NCT02372682 Shear Wave Sonoelastography in Pediatric Liver Fibrosis https://ClinicalTrials.gov/show/NCT02372682 Completed St. Louis University 2018-05-31
NCT03245606 Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03245606 Active, not recruiting Rennes University Hospital 2020-07-07
NCT02315586 Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02315586 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT02419989 PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT02419989 Recruiting National Jewish Health 2023-03-31
NCT02551588 Valvular Aortic Stenosis: Study of Myocardiac Fibrosis by Magnetic Resonance Imagery https://ClinicalTrials.gov/show/NCT02551588 Completed Assistance Publique - Hôpitaux de Paris 2015-11-30
NCT01805713 Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung https://ClinicalTrials.gov/show/NCT01805713 Completed University of Minnesota 2017-12-31
NCT01661491 Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01661491 Recruiting Yale University 2020-12-31
NCT04402801 Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04402801 Enrolling by invitation University of Virginia 2021-05-31
NCT04392544 Intestinal Inflammation in CF Patients https://ClinicalTrials.gov/show/NCT04392544 Recruiting The Hospital for Sick Children 2021-03-31
NCT03641742 Families-At-risk for Interstitial Lung Disease Study https://ClinicalTrials.gov/show/NCT03641742 Recruiting Columbia University 2035-10-01
NCT03509194 Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver Insufficiency https://ClinicalTrials.gov/show/NCT03509194 Recruiting Rigshospitalet, Denmark 2020-12-17
NCT03443934 Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment https://ClinicalTrials.gov/show/NCT03443934 Recruiting Hvidovre University Hospital 2023-04-30
NCT04024423 Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04024423 Recruiting National Jewish Health 2021-07-01
NCT03225677 Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis https://ClinicalTrials.gov/show/NCT03225677 Recruiting The Cleveland Clinic 2021-07-30
NCT00788359 Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation https://ClinicalTrials.gov/show/NCT00788359 Completed University of Colorado, Denver 2012-07-31
NCT00779077 Cystic Fibrosis (CF) Flow Rates Study https://ClinicalTrials.gov/show/NCT00779077 Completed Pharmaxis 2009-02-28
NCT00777725 Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart Failure https://ClinicalTrials.gov/show/NCT00777725 Completed Monash University 2010-10-31
NCT00760071 Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF) https://ClinicalTrials.gov/show/NCT00760071 Completed German Cancer Research Center 2008-10-31
NCT00758771 Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents https://ClinicalTrials.gov/show/NCT00758771 Completed University of California, San Francisco 2012-12-31
NCT00744939 Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist https://ClinicalTrials.gov/show/NCT00744939 Completed Bayer 2013-07-31
NCT00708617 FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT00708617 Completed Assistance Publique - Hôpitaux de Paris 2013-07-31
NCT00673101 Prospective Evaluation of FibroScan in Patients Treated With Methotrexate https://ClinicalTrials.gov/show/NCT00673101 Completed Association HGE CHU Bordeaux Sud 2019-07-31
NCT00670579 Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF) https://ClinicalTrials.gov/show/NCT00670579 Completed University of Florence 2009-10-31
NCT00669760 Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT00669760 Completed University Hospital Muenster 2011-07-31
NCT00611182 Dyspnea in Patients With Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00611182 Completed University of California, San Francisco 2010-03-31
NCT00590330 Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs https://ClinicalTrials.gov/show/NCT00590330 Completed Boston Children’s Hospital 2009-03-31
NCT00585364 Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA https://ClinicalTrials.gov/show/NCT00585364 Completed University of Pittsburgh 2010-12-31
NCT00577252 Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00577252 Completed Akron Children’s Hospital NA
NCT00531531 Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00531531 Completed University of Florence 2008-08-31
NCT00515567 Explanted Lung Tissues With Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00515567 Recruiting University of Chicago 2020-12-31
NCT00512967 The Occurence of Inflammation and Oxidative Stress in Lung Diseases https://ClinicalTrials.gov/show/NCT00512967 Completed Maastricht University Medical Center NA
NCT00504621 The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis https://ClinicalTrials.gov/show/NCT00504621 Completed Maastricht University Medical Center 2008-10-31
NCT00504361 Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) https://ClinicalTrials.gov/show/NCT00504361 Completed Weill Medical College of Cornell University 2012-05-31
NCT00488917 Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study) https://ClinicalTrials.gov/show/NCT00488917 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2009-08-31
NCT00485082 Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner https://ClinicalTrials.gov/show/NCT00485082 Completed National Institutes of Health Clinical Center (CC) 2008-03-21
NCT00470327 A Study of the Natural Progression of Interstitial Lung Disease (ILD) https://ClinicalTrials.gov/show/NCT00470327 Recruiting University of Chicago 2020-12-31
NCT00466336 Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices https://ClinicalTrials.gov/show/NCT00466336 Completed National Taiwan University Hospital 2006-12-31
NCT00466271 Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study https://ClinicalTrials.gov/show/NCT00466271 Completed National Taiwan University Hospital 2008-11-30
NCT01116414 Molecular Phenotypes for Cystic Fibrosis Lung Disease https://ClinicalTrials.gov/show/NCT01116414 Enrolling by invitation University of North Carolina, Chapel Hill 2020-04-30
NCT00457301 Using Health-related Quality of Life (HRQL) in Routine Clinical Care https://ClinicalTrials.gov/show/NCT00457301 Completed University of Alberta 2007-04-30
NCT00453713 Race, Ethnicity, and Diffuse Parenchymal Lung Disease https://ClinicalTrials.gov/show/NCT00453713 Completed Columbia University 2013-08-31
NCT00413140 Non-Invasive Biomarkers in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00413140 Completed Maastricht University Medical Center NA
NCT00404859 FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00404859 Completed Maastricht University Medical Center NA
NCT00381628 Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations https://ClinicalTrials.gov/show/NCT00381628 Completed University Hospitals Cleveland Medical Center 2011-09-30
NCT00373841 Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT00373841 Recruiting University of Pittsburgh 2025-07-31
NCT00360503 Antimicrobial Resistance in Cystic Fibrosis (CF) https://ClinicalTrials.gov/show/NCT00360503 Completed Seattle Children’s Hospital NA
NCT00333957 Capsule Endoscopy in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00333957 Completed Hadassah Medical Organization NA
NCT00323167 Rare Genetic Disorders of the Breathing Airways https://ClinicalTrials.gov/show/NCT00323167 Completed University of North Carolina, Chapel Hill 2012-10-31
NCT00311506 A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease https://ClinicalTrials.gov/show/NCT00311506 Completed Genentech, Inc. 2004-06-30
NCT00266474 Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00266474 Completed University of Jena NA
NCT00258570 Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT00258570 Recruiting University of Pittsburgh 2025-07-31
NCT00250315 DOCICAR: Cardiac Dysfunction in Cirrhosis https://ClinicalTrials.gov/show/NCT00250315 Completed Hvidovre University Hospital NA
NCT00245310 Indocyangreen Elimination in Cirrhosis and Acute Liver Failure https://ClinicalTrials.gov/show/NCT00245310 Completed Heidelberg University 2010-10-31
NCT00228670 Herpesvirus in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00228670 Completed Emory University 2012-08-31
NCT00222508 The Microvascular Complications Study https://ClinicalTrials.gov/show/NCT00222508 Completed University of Minnesota NA
NCT00221559 Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group https://ClinicalTrials.gov/show/NCT00221559 Completed University Hospital, Ghent NA
NCT00806455 Exercise-Induced Bronchospasm in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00806455 Completed Ohio State University 2013-08-31
NCT00043225 The Role of Bacteria and Genetic Variations in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00043225 Completed National Institutes of Health Clinical Center (CC) NA
NCT00037778 Genetic Modifiers of Cystic Fibrosis: Sibling Study https://ClinicalTrials.gov/show/NCT00037778 Completed Johns Hopkins University 2013-02-28
NCT00037765 Gene Modifiers of Cystic Fibrosis Lung Disease https://ClinicalTrials.gov/show/NCT00037765 Active, not recruiting University of North Carolina, Chapel Hill 2021-07-31
NCT00027183 Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa https://ClinicalTrials.gov/show/NCT00027183 Completed National Institutes of Health Clinical Center (CC) NA
NCT00750932 Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00750932 Completed University Hospital, Tours 2012-01-31
NCT00727285 Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies https://ClinicalTrials.gov/show/NCT00727285 Completed National Jewish Health 2011-10-31
NCT00258544 Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT00258544 Active, not recruiting University of Pittsburgh 2025-07-31
NCT00015756 Tissue Collection From People With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00015756 Completed National Institutes of Health Clinical Center (CC) NA
NCT00008762 Bone Health of People With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00008762 Completed National Center for Research Resources (NCRR) NA
NCT00014781 Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00014781 Completed Office of Rare Diseases (ORD) NA
NCT00005317 Idiopathic Pulmonary Fibrosis–Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases https://ClinicalTrials.gov/show/NCT00005317 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005295 Idiopathic Pulmonary Fibrosis: a Case-control Study https://ClinicalTrials.gov/show/NCT00005295 Completed University of New Mexico NA
NCT00001885 Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001885 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001884 Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001884 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001876 Lung Disease Associated With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001876 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001618 Segmental Bronchoalveolar Lavage https://ClinicalTrials.gov/show/NCT00001618 Completed National Institutes of Health Clinical Center (CC) NA
NCT00016627 Linkage Study in Familial Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00016627 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00004296 Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT00004296 Completed Office of Rare Diseases (ORD) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03342170 Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis? https://ClinicalTrials.gov/show/NCT03342170 Completed University Hospital, Caen 2019-12-31
NCT03267615 VICIS - Vienna Cirrhosis Study https://ClinicalTrials.gov/show/NCT03267615 Recruiting Medical University of Vienna 2026-12-31
NCT03263598 Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites https://ClinicalTrials.gov/show/NCT03263598 Completed Keimyung University Dongsan Medical Center 2020-02-29
NCT02908048 Extracellular RNA Markers of Liver Disease and Cancer https://ClinicalTrials.gov/show/NCT02908048 Active, not recruiting Mayo Clinic 2021-07-31
NCT02907788 Inflammatory Markers in Broncho-alveolar Lavage Fluid as Risk Factors for Lung Disease in Infants With Cystic Fibrosis: the I-BALL Study https://ClinicalTrials.gov/show/NCT02907788 Recruiting Erasmus Medical Center 2022-12-31
NCT02846896 The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland https://ClinicalTrials.gov/show/NCT02846896 Completed Fondazione Epatocentro Ticino 2016-09-30
NCT02828254 A Follow-up Evaluation Study of PRI-724-1101 https://ClinicalTrials.gov/show/NCT02828254 Completed Komagome Hospital 2017-03-27
NCT02772549 Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay https://ClinicalTrials.gov/show/NCT02772549 Recruiting University Hospital, Gentofte, Copenhagen 2022-12-31
NCT02758808 Pulmonary Fibrosis Foundation Patient Registry https://ClinicalTrials.gov/show/NCT02758808 Recruiting University of Michigan 2021-03-31
NCT02693847 Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients https://ClinicalTrials.gov/show/NCT02693847 Recruiting Hospital Universitario de Valme 2020-12-31
NCT02031913 Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD https://ClinicalTrials.gov/show/NCT02031913 Recruiting Seoul National University Boramae Hospital 2022-11-30
NCT02551250 Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02551250 Active, not recruiting Seoul St. Mary’s Hospital 2019-12-31
NCT02449031 Observational Study in Cystic Fibrosis Patients Using TOBI® Podhaler™ or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs https://ClinicalTrials.gov/show/NCT02449031 Active, not recruiting Mylan Inc. 2023-07-31
NCT02309229 Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial. https://ClinicalTrials.gov/show/NCT02309229 Completed Universitaire Ziekenhuizen Leuven 2013-12-31
NCT02292706 A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection https://ClinicalTrials.gov/show/NCT02292706 Active, not recruiting Gilead Sciences 2023-01-31
NCT02206841 Establishment of NAFLD Cohort and Development of Fibrosis Markers https://ClinicalTrials.gov/show/NCT02206841 Recruiting Seoul National University Boramae Hospital 2020-08-31
NCT02133313 Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis https://ClinicalTrials.gov/show/NCT02133313 Completed University of Alabama at Birmingham 2017-03-31
NCT02043717 Increased Vitamin D Reduces Pulmonary Exacerbations in CF https://ClinicalTrials.gov/show/NCT02043717 Completed Hadassah Medical Organization 2015-01-31
NCT02038517 Cirrhosis, Effects of TRAnsplantation and Diabetes https://ClinicalTrials.gov/show/NCT02038517 Recruiting Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico 2016-12-31
NCT01962155 Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters https://ClinicalTrials.gov/show/NCT01962155 Completed Peking University First Hospital 2015-12-31
NCT01943318 Boramae Hospital Liver Cirrhosis Patient Cohort Study https://ClinicalTrials.gov/show/NCT01943318 Recruiting Seoul National University Boramae Hospital 2022-10-31
NCT01935726 Pulmonary Fibrosis Contact Registry https://ClinicalTrials.gov/show/NCT01935726 Completed National Jewish Health 2019-03-10
NCT01915511 Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry https://ClinicalTrials.gov/show/NCT01915511 Recruiting Duke University 2025-01-31
NCT01906047 Impact of Chronic Air Pollution on Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01906047 Completed Universitaire Ziekenhuizen Leuven 2012-10-31
NCT04422223 Prospective Cohort Study of Disease and Outcomes in Cirrhosis https://ClinicalTrials.gov/show/NCT04422223 Recruiting Copenhagen University Hospital, Hvidovre 2024-12-30
NCT04326946 International Alfapump Cohort Study https://ClinicalTrials.gov/show/NCT04326946 Recruiting Sequana Medical N.V. 2023-12-31
NCT04329559 COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study https://ClinicalTrials.gov/show/NCT04329559 Recruiting Hepatopancreatobiliary Surgery Institute of Gansu Province 2020-06-29
NCT04312854 A Prospective Cohort Study of IRPF in China https://ClinicalTrials.gov/show/NCT04312854 Recruiting Peking Union Medical College Hospital 2030-01-31
NCT04277819 The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management https://ClinicalTrials.gov/show/NCT04277819 Recruiting Manchester University NHS Foundation Trust 2020-08-30
NCT04259983 Investigation of Relationship Between Vascular Functions, Exercise Capacity, and Respiratory Functions in CF https://ClinicalTrials.gov/show/NCT04259983 Active, not recruiting Hacettepe University 2022-01-08
NCT04184934 Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal Hemorrhage https://ClinicalTrials.gov/show/NCT04184934 Enrolling by invitation Taipei Veterans General Hospital, Taiwan 2020-01-30
NCT04160715 Korean Idiopathic Pulmonary Fibrosis Registry https://ClinicalTrials.gov/show/NCT04160715 Recruiting Seoul National University Hospital 2025-01-31
NCT04106518 Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT04106518 Recruiting University Hospital, Lille 2022-10-31
NCT04016181 The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study https://ClinicalTrials.gov/show/NCT04016181 Enrolling by invitation University of Edinburgh 2022-03-31
NCT03989973 Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03989973 Recruiting West China Hospital 2022-09-01
NCT03842748 Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis https://ClinicalTrials.gov/show/NCT03842748 Recruiting Beijing Municipal Administration of Hospitals 2021-12-30
NCT03747627 BPF Genetics of ILD Study https://ClinicalTrials.gov/show/NCT03747627 Recruiting NHS Forth Valley 2024-01-22
NCT03732859 PROOF-Registry New and Extended Belgium -Luxembourg https://ClinicalTrials.gov/show/NCT03732859 Recruiting Belgian Thoracic Society 2021-01-09
NCT03676777 Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China https://ClinicalTrials.gov/show/NCT03676777 Recruiting Ruijin Hospital 2019-12-31
NCT03666234 Idiopathic Pulmonary Fibrosis Registry China Study https://ClinicalTrials.gov/show/NCT03666234 Recruiting China-Japan Friendship Hospital 2023-06-30
NCT03599882 Liver Steatosis and Stiffness in HIV https://ClinicalTrials.gov/show/NCT03599882 Recruiting Chang Gung Memorial Hospital 2018-12-31
NCT00540475 Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry https://ClinicalTrials.gov/show/NCT00540475 Completed University of Pittsburgh 2018-07-31
NCT02407431 PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort https://ClinicalTrials.gov/show/NCT02407431 Active, not recruiting University of Pittsburgh 2020-09-30